Answer
During loncastuximab tesirine treatment, women of childbearing potential and men with partners of childbearing potential should use effective contraception, continuing for at least 10 months for women and 7 months for men after the last dose.
Sources for this answer
- Zynlonta, 10mg, powder for concentrate for solution for infusionSwedish Orphan Biovitrum Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 6Document updated
Sources checked